Post by Daniel I.

I’m glad to have contributed to a new paper on a problem that is all too familiar in Sub Saharan Africa: therapeutic market failure. In this case, snakebite, which continues to kill tens of thousands of people across the continent each year. The need is clear, but it reaches manufacturers as fragmented and often unreliable signals, shaped by uneven funding and stop start procurement. Faced with that uncertainty, suppliers underinvest, and shortages follow. We have seen this change when demand becomes more visible and reliable. Pooled procurement and advance market commitments have helped shape markets for vaccines and essential medicines, lowering prices and stabilising supply across several African countries. In the paper, we focus on a few financing priorities: - Aggregating demand so markets are clearer and more predictable - Aligning financing with long term investment in local production - Using blended finance to unlock capital at scale Get the financing right, and the rest becomes much easier. Grateful for the collaboration and insights of Ini Umoh, Ezekiel Boro, Charles McLoughlin, Tianyi Frank-Leonel, George Oluoch, Ian Burn, Becky Jones-Phillips, and Nicholas Casewell. Read more here: https://lnkd.in/eFDXyjVZ